Duchenne muscular dystrophy (DMD) is a muscle disease with serious cardiac complications. Changes in Ca 2+ homeostasis and oxidative stress were recently associated with cardiac deterioration, but the cellular pathophysiological mechanisms remain elusive. We investigated whether the activity of ryanodine receptor (RyR) Ca 2+ release channels is affected, whether changes in function are cause or consequence and which post-translational modifications drive disease progression.
Introduction
Cytoskeletal remodelling often accompanies cardiac hypertrophy and failure. 1 Dystrophinopathies represent a unique group of diseases in which the cytoskeletal disarray is not only a consequence but also the cause of the disease. They result from mutations in the dystrophin gene. 2 Duchenne muscular dystrophy (DMD) is among the most severe forms of dystrophy. Cardiac manifestations of the disease are present in the majority of adolescent boys with DMD. About 20% of the patients suffer from ventricular dysfunctions and arrhythmias that ultimately lead to heart failure or sudden cardiac death. 3 The most commonly used animal model of DMD is the mdx mouse, which lacks dystrophin. Mdx mice develop dilated cardiomyopathy over an 8-month period. 4, 5 By that age they also show electrocardiographic and magnetic resonance imaging abnormalities and develop sustained ventricular tachycardia when challenged with isoproterenol. The cellular pathology of the failing heart often shows impaired intracellular Ca 2+ homeostasis, including abnormal excitationcontraction (EC) coupling. 7 It is well described that at different stages of dystrophic cardiomyopathy its cellular phenotype exhibits augmented intracellular Ca 2+ responses (i.e. a burst of Ca 2+ sparks and waves) to mechanical stress, 8 -10 hypersensitive EC-coupling, 11 increased Ca 2+ leak from the sarcoplasmic reticulum (SR), and reduced SR Ca 2+ load. 6 These features clearly point to modifications in intracellular Ca 2+ cycling and suggest elevated activity of Ca 2+ -induced Ca 2+ release (CICR) from the SR via ryanodine receptor (RyR). As underlying causes, several and probably not mutually exclusive mechanisms of RyRs sensitization have been considered. They include oxidative 9 and nitrosative 6 post-translational modifications of RyRs as well as their phosphorylation by PKA. 12 However, a causal links between these modifications and alterations of RyR function, development of cellular abnormalities and progression of dystrophic cardiomyopathy have not yet been established clearly. The aim of this study was to define the interactions among several cellular pathomechanisms that converge to a common endpointthey ultimately all sensitize or even hypersensitize the CICR machinery, in particular the RyRs. In addition, we wanted to determine whether RyR hypersensitivity to Ca 2+ precedes and therefore possibly underlies the progression of this disease. We found that gradually developing and additive modifications of RyRs provoke the degradation of cardiomyocyte function that may ultimately result in cardiac failure in muscular dystrophy.
Methods
For additional information on methods, see Supplementary material online.
Cell isolation
All experiments conformed with the NIH Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH publication, 8th edition, 2011) and were approved by the Institutional Animal Care and Use Committee of the New Jersey Medical School, USA and by the State Veterinary Office of Bern, Switzerland. C57BL10 mice (wild-type, WT) and dystrophin-deficient mdx (C57BL/ 10ScSn-mdx) mice at the age of 1 (young), 3 -4 (adult), and 12 -15 months (senescent) were used in this study. Animals were purchased from the Jackson Laboratory. Ventricular myocytes were enzymatically isolated as previously described. 13 Briefly, mice were heparinized (5000 U/kg), anaesthetized with sodium pentobarbital (100 mg/kg), and checked to ensure the absence of movement, flexor, and pedal reflexes. Hearts were then quickly removed, mounted on a Langendorff apparatus and perfused with a solution containing collagenase and protease. Ventricles were cut into small pieces from which cells dissociated with time.
Myocytes were used for experiments within 5 h after isolation.
Cellular experiments
Changes in cytoplasmic [Ca 2+ ] and production of reactive oxygen species (ROS) were monitored with fluorescent indicators fluo-3 AM (5 mM) and 5-(and-6)-chloromethyl-2 ′ ,7 ′ -dichlorodihydrofluorescein diacetate (CM-H 2 DCFD, 20 mM), respectively, and a laser-scanning confocal microscope (Bio-Rad, Radiance 2000) in XY-scan mode at the rate of 0.5 Hz. Dyes were excited with the 488 nm line of an Argon laser. The emitted light was collected above 500 nm. SR Ca 2+ leak was estimated as described in The content of free thiols was determined using a monobromobimane (mBB, Calbiochem, USA) assay. 16 Isolated cardiomyocytes were permeabilized and incubated with 1 mM mBB for 1 h in a dark room. The proteins were separated in 4 -15% TGX SDS-gels (Bio-Rad, CA, USA) and imaged with UV excitation (360 nm). Total RyR2 was determined from Coomassie blue staining of gels run in parallel and confirmed by western blotting with anti-RYR2 (Thermo Scientific, MA, USA) and mass spectrometry at UMDNJ core facility.
Statistics
Results are shown as mean + standard error (SEM Figure 1A) . Since the extent of Ca 2+ influx is only slightly 
Hypersensitivity of RyRs is driven by oxidation in young mdx myocytes
There is a number of post-translational modifications that may contribute to the increased sensitivity of RyR activation by Ca 2+ . Oxidation, nitrosation, and phosphorylation are among them. Oxidative modification of RyRs was one of the first proposed mechanisms contributing to an impaired Ca 2+ homeostasis of dystrophic cardiomyocytes. 9, 21 Moreover, an increased activity of plasmalemmal NAD(P)H oxidase (NOX) was identified to be a major source of oxidative stress in dystrophic cardiomyopathy. 9, 10, 21 Here we tested whether oxidative stress modifies RyR functions already in very early stages of the disease. Four groups of experiments were performed: we (i) compared the extent of ROS production in WT and mdx cardiomyocytes with confocal microscopy and CM-H 2 DCFDA; (ii) assessed the oxidation and phosphorylation status of RyRs using mBB assays and phospho-specific antibodies against RyR PKA and CaMKII sites Ser-2808 and Ser-2814; (iii) evaluated the oxidative status of CaMKII with antiserum against oxidized Met281/282 residues; and (iv) tested whether scavengers of ROS, inhibitors of NOX, CaMKII, PKA, and various isoforms of nitric oxide synthase (eNOS, nNOS and iNOS) 'normalize' hypersensitive Ca 2+ responses to osmotic shock and EC-coupling in dystrophic myocytes.
To assess oxidative stress, myocytes isolated from WT and mdx mice were identically loaded with CM-H 2 DCFDA. CM-H 2 DCFDA is hydrolyzed to DCFH in the cell, and DCFH is oxidized to form the highly fluorescent DCF compound in the presence of an appropriate oxidant. It should be noted that, as many other ROS indicators, DCF is not exclusively selective to detect ROS, but also some reactive nitrogen species (RNS). DCF-related fluorescence was followed for 3 min under resting conditions ( Figure 2A ). The slope of the averaged DCF signal largely reflects the rate of cellular ROS production. It was significantly greater in mdx cells. Another way to assess the redox state of the cytosol is to normalize resting DCF fluorescence (F 0 ) to the signal after addition of 10 mM H 2 O 2 (F max ). The relative increase of fluorescence after the addition of H 2 O 2 was significantly smaller in mdx myocytes, also indicating an increased resting ROS/ RNS level in dystrophic hearts of young animals. Purified cardiac RyR tetramer contains multiple free cysteines 22 which can be readily oxidized. The content of free thiols in RyRs was determined with the mBB technique. Relative content of free thiols in RyR was 70% greater in WT, suggesting that oxidative stress in dystrophic cells resulted in oxidation of RyRs ( Figure 2B ).
RyRs are also predisposed to phosphorylation by both CaMKII and PKA. Moreover, CaMKII itself is susceptible to oxidative activation. Table S1 for details.
Cellular phenotype of cardiac dystrophy
Based on our data, the enzyme is expected to be more actively involved in mdx cardiomyocytes, as the amount of oxidized enzyme increased about 2-fold in dystrophic cells ( Figure 2C) . We assessed the phosphorylation status of RyRs with phospho-specific antibodies against Ser-2814 (putative phosphorylation site for CaMKII) and Ser-2808 (proposed site for PKA phosphorylation). These experiments indicate that CaMKII-, but not PKA-mediated phosphorylation, also contribute to the early cellular dysfunctions in dystrophic cardiomyopathy ( Figure 2D ). To further evaluate the contribution of each particular posttranslational RyR modification, a set of functional studies with various pharmacological tools was carried out. Figure 2E illustrates that the reducing agent 2-mercaptopropionyl glycine (MPG, 1 mM), inhibitors of NOX (apocynin, 0.5 mM and diphenylene iodonium, 10 mM) and CaMKII [K-93, 5 mM and autoctamide-2-related inhibitory peptide (AIP), 2.5 mM] reversibly inhibited intracellular Ca 2+ responses to osmotic shock and normalized EC-coupling in mdx cells. In contrast, various PKA inhibitors (H89, 5 mM, KT5720, 2 mM, and PKA inhibitory peptide (PKI), 5 mM) as well as inhibitors of nNOS, eNOS, and iNOS (S-methyl-L-thiocitrulline, 10 mM and 1400 W, 100 nM, respectively) had no significant effect on the intracellular Ca 2+ signals in mdx myocytes from young animals (see Supplementary material online, Table S1 for details). Note that after testing a broad range of inhibitors of PKA and CaMKII in the experiments with osmotic shock, we used only the more specific inhibitory peptides of kinases (AIP and PKI) in subsequent work. Right panel in Figure 2D shows that 'hypersensitive' gain of EC coupling in dystrophic cells was also normalized by reducing factors and inhibitors of NOX and CaMKII but was not affected by inhibitors of PKA or NOS. These results are in agreement with biochemical studies by us and others, 6, 19 which did not reveal changes in PKA-phosphorylation or nitrosative status of RyRs in very young mdx hearts. Taken together, the findings presented so far are consistent with the hypothesis that oxidative stress due to an increased production of ROS by NOX drives the cellular pathology of cardiac dystrophy at very early stages of the disease.
The progression of cellular pathology in cardiac dystrophy
Data presented above suggest that cellular abnormalities in isolated dystrophic cardiomyocytes clearly precede the first clinical signs of cardiomyopathy. 4, 5 Here we followed up on the progression of the cellular phenotype of the disease to the age where heart dysfunction becomes prominent. Ventricular myocytes were isolated from 3-4-and 12-15-month-old animals. Similar to the experiments shown above, intracellular Ca 2+ responses to mild osmotic shock, EC-coupling, SR Ca 2+ leak, and load were examined. Data are summarized in Figure 3 , which also includes some results from 1-month-old mice adapted from Figure 1 for comparison. With the progression of the disease, more mdx cardiomyocytes exhibited excessive intracellular Ca 2+ responses to osmotic shock (74, 90, and 95% for the three age groups studied, respectively). EC coupling became extremely hypersensitive at the age of 3-4 months (just before the clinical onset of the disease), but sensitivity remained relatively high in the senescent animals. Figure 3B ). We also carried out experiments similar to those illustrated in Figure 2 . It seems that by the age of 3-4 months (just before the appearance of clinical signs of cardiac dystrophy) several posttranslational modifications additively enhance RyR function resulting in increased SR Ca 2+ leak, reduced SR Ca 2+ content, and consequently impaired force production by the individual myocytes. In cells from mdx mice older than 3 months, activation of NOS and PKA also seems to contribute to the hypersensitivity, possibly further aggravating the disease at later stages. A variety of pharmacological tools supports this conclusion as they not only normalized intracellular Ca 2+ responses during mechanical stress and EC coupling in older animals ( Figures 4A and B , and 5) but also significantly reduced intracellular Ca 2+ leak in senescent mice ( Figure 4C ).
Discussion
Most cardiac diseases are accompanied by substantial remodelling of the heart tissue, also on cellular and molecular level. 24 Depending on the cause of the illness and the particular pathophysiology, various adaptive remodelling mechanisms can initially compensate for the functional impairments. Unfortunately, some of these initially beneficial processes can become maladaptive with time and during progression of the illness, finally aggravating rather than improving the cardiac condition. This interplay between (i) defects causing a cardiac disease and (ii) the remodelling mechanisms that try to maintain function leads to a very complex situation. This complexity makes it extremely challenging to unravel the causal disease mechanisms and to comprehend the evolution of the disease. However, such an understanding would greatly facilitate the development of new therapies and the identification of new drug targets. shock, individual intracellular Ca 2+ responses were averaged within each experimental group (e.g. each pharmacological intervention applied) and normalized to the averaged response under control conditions (no drug applied). In the EC-coupling gain experiments, averaged data within each experimental group were also normalized to the values obtained in control (no drug applied) conditions. Details are in Supplementary material online, Table S1 .
Cellular phenotype of cardiac dystrophy
One possible strategy to gain insight into the interplay between causal and adaptive alterations of cardiac muscle is to follow the disease progression over longer periods of time. This approach is based on the rationale that causal changes can presumably be identified from the beginning of the disease, even before the pathology becomes manifest, while adaptive and maladaptive processes will develop at later stages only.
Based on this reasoning we carried out the present study, examining disease progression in dystrophic cardiomyopathy. Because of their slowly developing cardiac phenotype, mdx mice are a useful model for studies of the progression of DMD that can help to identify the cellular sequence of events leading from the genetic defect (lack of functional dystrophin) to the onset of cardiac disease. Hearts of 1-to 2-month-old mdx mice seem to have normal morphology, left ventricular function, and echocardiograms. First signs of cardiac disease, such as reduced left ventricular filling, ejection fraction, and ejection rate, are seen only in 3-month-old animals. These changes are more prominent and can be detected earlier in the right ventricle. By 8 months of age, hearts from mdx mice are dilated, hypertrophied, somewhat fibrotic, and poorly contracting. 4 21 In addition, measurements in dystrophic mdx papillary muscles revealed that the myofibrillar Ca 2+ sensitivity is reduced, a finding which contributes to the weak force, in addition to the smaller Ca 2+ transients. 26 Additionally, electrocardiographic (ECG) deviations such as diminished R-and S-wave amplitudes gradually become apparent in mdx mice. By the age of 6 months shortening of the PR interval and polymorphic R-waves suggest disturbances in the cardiac conduction system. 27, 28 While in the mdx mouse cardiomyopathy only becomes apparent in adulthood, the dystrophin protein is absent throughout the lifetime of the animal. Thus, functional consequences of the lack of dystrophin, such as stress sensitivity, would be expected to be present even in very young and apparently healthy mice. For our study, we focussed on the presently prevailing hypothesis to explain the damages caused by the lack of this protein, which links cytoskeletal proteins with the cell environment: the 'Ca 2+ hypothesis of muscular dystrophy'. 29 This hypothesis proposes that the membrane fragility resulting from the lack of dystrophin leads to extra influx of Ca 2+ via micro-ruptures and/or stretch activated channels, and that these Ca 2+ signals are subsequently amplified by CICR and ultimately lead to activation of Ca 2+ activated proteases, to mitochondrial damage and apoptotic or necrotic cell death. This hypothesis has recently been elaborated to contain another aggravating culprit, excessive oxidative stress. Our results obtained using cardiomyocytes isolated from young animals now suggest that the oxidative stress is possibly among the very initial problems dystrophic myocytes encounter ( Figure 5) . In these cells, ROS production was already abnormally high. Furthermore, ROS scavengers and inhibitors of NAD(P)H oxidase could prevent most of the acute Ca 2+ signalling alterations, suggesting NOX as the primary source of this oxidative stress. Why and how Our studies further suggest that later during the progression of dystrophic cardiomyopathy, but before heart failure is observed, nitrosation and PKA-dependent phosphorylation contribute to the increased sensitivity of RyRs to Ca 2+ , in agreement with recently published data. 6, 19, 36 At this stage of the disease, mdx mice and DMD patients often exhibit electrocardiographic abnormalities, such as premature ventricular beats. Moreover, during physical or emotional stress, CPVTs have also been reported in boys with DMDs. 35 It is possible that under these conditions additional b-adrenergic input may lead to SERCA and I Ca stimulation, followed by phosphorylation of the RyRs, culminating in a high arrhythmogenic potential due to overloaded SR and hypersensitive RyRs. 19 Finally, our data indicate that at the terminal stages of cardiac dystrophy, several post-translational modifications together hypersensitize RyR to an extent where SR Ca 2+ leak dramatically increases. This may Table S1 .
Cellular phenotype of cardiac dystrophy subsequently contribute to cytosolic and mitochondrial Ca 2+ overload, 9 ,17 activation of necrotic and apoptotic processes, and loss of functional myocytes. The latter step usually precedes the development of cardiac fibrosis and reduction in heart contractility. 4 In parallel, enhanced and uncompensated SR Ca 2+ leak results in a reduction in SR Ca 2+ load, which will in turn reduce the amplitude of beat-to-beat intracellular Ca 2+ transients, thus resulting in reduced force production by the surviving cardiomyocytes. These two cellular processes could eventually impede cardiac contractility leading to cardiac failure.
Conclusions
The present study revealed the gradual time-dependent unfolding of prominent disease pathomechanisms in dystrophic hearts. Our major conclusion is that overall oxidative stress may be more important as one of the early steps of an initial cellular injury than previously thought. We suggest that the 'Ca 2+ hypothesis' of cardiac dystrophy should be significantly modified as it was previously implemented for skeletal muscle disease. 37 Obviously, this view should also be considered when developing new therapies for muscular dystrophy. One can speculate that therapies could even benefit from a combined approach, where oxidative stress and RyR hypersensitivity would be targeted simultaneously.
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